Home > Drug Search >
  • Targets: Pyruvate dehydrogenase complex (PDC)
  •   > 
Drug Filter
Status:
Approved (1) Phase Ⅲ (1) Phase Ⅱ (11) Phase Ⅰ (3)
Clinical Stage:
Pending (2) Active (6) Discontinued (8)
Company:
GlaxoSmithKline (4) Japan Tobacco (1) Merck Serono (1) Neurocrine Biosciences (2) Ono Pharmaceutical (1) Pfizer (1) Sanofi (2) Wakunaga (1) Unknown (1) Neugen (1) Komipharm (1) Reata (1) NIAAA (2) Canopus (1) Cornerstone Pharmaceuticals (1) PreScience Labs (1) Johns Hopkins University (1) Valens (2) Mallinckrodt Pharmaceuticals (1) Abbvie (1)
Indication:
Amyotrophic lateral sclerosis (ALS) (1) Anxiety (3) Breast cancer (1) Depression (3) Friedreich's ataxia (1) Hepatocellular carcinoma (HCC) (1) Irritable bowel syndrome (IBS) (2) Lung cancer (2) Major depressive disorder (MDD) (1) Myelodysplastic syndrome (MDS) (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Pancreatic cancer (2) Prostate cancer (1) Skin infectious (1) Small cell lung cancer (SCLC) (1) Type 2 diabetes (1) Reperfusion injury (1) Post-traumatic stress disorder (2) Skin ulcer (1) Alcoholism (2) Chemotherapy-radiotherapy induced mucositis (1) Ischemic stroke (1) Traumatic brain injury (1) Burns (1) Ocular pain (1) Myocardia ischemia (1) Congenital lactic acidosis (1) Ocular inflammation (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top